Connecting scientific discovery with meaningful development decisions.

AionWell is a U.S.-based translational life sciences company focused on the evidence that connects biological discovery with therapeutic development.

We bring together scientific analysis, molecular research, and preclinical imaging to support teams investigating disease mechanisms, biological targets, and therapeutic candidates.

The Company

From discovery to decision-ready evidence.

Our approach emphasizes fit-for-purpose experimental design, quantitative interpretation, and scientific rigor. We are also developing AI-enabled approaches to make biomedical research evidence more structured, traceable, and useful for development decisions.

Our current focus includes oncology, radiopharmaceutical research, and targeted therapeutic development. Over the longer term, we aim to apply these capabilities to aging biology, age-related diseases, and healthy longevity.

We believe advances in medicine depend not only on what science can discover, but also on what research can reliably demonstrate.

Our Journey

AionWell is best understood as a line of work rather than a finished platform: a question we keep returning to, a method for answering it, and an honest account of where each part stands.

01 — The question

Therapeutic development turns on decisions — which target to commit to, which candidate to advance, which study to run next. Behind each one sits a harder question: what evidence actually supports this decision, and what is still missing? Programs often carry findings from different models, assays, and publications that do not fully agree. AionWell starts there — with the gap between the decision that has to be made and the evidence that exists.

02 — The method

Our response is to read the evidence together rather than in pieces. Structured evidence assessment weighs what already exists; molecular and biomarker research may generate evidence where it is missing; preclinical imaging may show where a candidate goes in a living system. Each line of evidence is interpreted against the research question it was meant to answer — and early work suggests the disagreements between lines of evidence are often where the useful information sits.

03 — The stage

We keep three maturity levels separate, and label them wherever they appear. Current focus areas — precision oncology, radiopharmaceutical research, and targeted therapeutic development — are where engagements can be scoped today. Developing technologies, including AI-enabled evidence tools, are in development and are not a validated platform. Aging biology is a long-term direction. What is not yet known — about our own methods as much as any program’s biology — is stated as plainly as what is.

Our Mission

Advancing human health and healthy longevity through rigorous science.

Scientific approach

Translational research is most useful when the scientific question, experimental method, and development decision are connected from the beginning. That principle structures everything from evidence assessment to integrated program design.

Research capabilities

Scientific evidence assessment, molecular and biomarker research, preclinical molecular imaging, and integrated research programs — described in full, with scope and limitations, on the Capabilities pages. Where specialized experimental resources are required, work may be coordinated through participating research organizations, each a separate legal entity.

Long-term vision

To extend the same evidence discipline to geroscience, age-related disease research, and emerging therapeutic technologies — without presenting that future direction as a present capability.

Our Principles

How we hold ourselves to the evidence.

01 Scientific Rigor

Interpret evidence within the limits of its methods and biological context.

02 Clarity

Communicate what is known, what is uncertain, and what remains to be tested.

03 Accountability

Maintain human responsibility for scientific conclusions.

04 Long-Term Thinking

Build scientific processes that retain value beyond individual projects.

05 Collaboration

Work with qualified experts and organizations through clear responsibilities and appropriately defined rights.

The AionWell Brand

One mark. Four commitments.

The AionWell mark combines a bold A above a V into a single monogram, finished with a small platinum parallelogram at the upper right of the V. It is the evidence path in visual form: beginning among biological forms, flowing through measured points, and resolving into a single decision point.

Longevity

健康长寿

The long-term direction: more years in good health, pursued through rigorous science — a direction, not a promised outcome.

Life Sciences

生命科学

Molecular and biological research as the foundation of every claim we make — measured directly, interpreted honestly.

AI and Data

AI 与数据

AI-enabled methods, in development, to make biomedical research evidence more structured, traceable, and useful.

Translation

转化与应用

Turning biological insight into decision-ready evidence that a development program can act on.